Milbank LLP represented the lenders in connection with the provision of $225 million revolving loan facilities for LivaNova USA, Inc., the US subsidiary of LivaNova PLC (Nasdaq: LIVN) (“LivaNova”). The proceeds of the facilities will be used for general corporate purposes.
LivaNova is a global medical device company headquartered in London.
The Milbank team was led by New York-based Global Leveraged Finance partner Lauren Hanrahan with assistance from special counsel Gabrielle Paolini Webster and associates Julia Wennberg, Michael Beyda and Joseph Principato.
